<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0255">
 <label>51</label>
 <element-citation publication-type="journal" id="rf0235">
  <person-group person-group-type="author">
   <name>
    <surname>Hsu</surname>
    <given-names>J.T.-A.</given-names>
   </name>
   <name>
    <surname>Kuo</surname>
    <given-names>C.-J.</given-names>
   </name>
   <name>
    <surname>Hsieh</surname>
    <given-names>H.-P.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.-C.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>K.-K.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>C.P.-C.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>P.-F.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Liang</surname>
    <given-names>P.-H.</given-names>
   </name>
  </person-group>
  <article-title>Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV</article-title>
  <source>FEBS Lett.</source>
  <volume>574</volume>
  <year>2004</year>
  <fpage>116</fpage>
  <lpage>120</lpage>
  <pub-id pub-id-type="doi">10.1016/j.febslet.2004.08.015</pub-id>
  <pub-id pub-id-type="pmid">15358550</pub-id>
 </element-citation>
</ref>
